{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:27:19Z","timestamp":1790720839379,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>People with intellectual disabilities (PwID) are frequently prescribed long-term antipsychotics for behaviours that challenge (BtC) despite the lack of proven effectiveness and the increased risks for side effects of these medications in this population. National and international good clinical practice guidelines recommend deprescribing antipsychotics for BtC, which is often not successful due to environmental and other factors. The involvement of all stakeholders, including PwID, is crucial for deprescribing. However, studies showed that PwID and\/or their families are often not involved in decision-making regarding the (de)prescribing of antipsychotics despite their desire to get involved. Moreover, studies on the views of PwID regarding their experiences of withdrawing from antipsychotics are lacking. The aim of this study was to gain insight into the views of PwID by investigating their experiences of discontinuation of long-term prescribed antipsychotics for BtC. A qualitative study was set up. Seven experts by experience with mild intellectual disabilities were interviewed. After six interviews, data saturation was achieved. Interviews were transcribed verbatim. Using phenomenological analysis, themes on lived experiences were extracted. Each consecutive interview was analysed. The four main themes extracted from the interviews were the quality of treatment, knowledge and information about psychotropics and the process of withdrawal, support from the participants\u2019 environment and the coping style of the interviewees themselves.<\/jats:p>","DOI":"10.3390\/ijerph192315637","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:05:37Z","timestamp":1669341937000},"page":"15637","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5315-2110","authenticated-orcid":false,"given":"Gerda","family":"de Kuijper","sequence":"first","affiliation":[{"name":"GGZ-Drenthe\/Centre for ID and Mental Health, 9404 LL Assen, The Netherlands"},{"name":"Academic Collaboration ID and Mental Health, University Medical Centre Groningen, 9713 GZ Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"de Haan","sequence":"additional","affiliation":[{"name":"GGZ-Drenthe\/Centre for ID and Mental Health, 9404 LL Assen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-8103","authenticated-orcid":false,"given":"Shoumitro","family":"Deb","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Brain Sciences, Imperial College London, London SW7 2BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-6933","authenticated-orcid":false,"given":"Rohit","family":"Shankar","sequence":"additional","affiliation":[{"name":"Peninsula School of Medicine, University of Plymouth, Plymouth PL4 8AA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ridd.2016.08.006","article-title":"Prevalence and putative risk markers of challenging behavior in students with ID","volume":"58","author":"Dworschak","year":"2016","journal-title":"Res. Dev. Disabil."},{"key":"ref_2","unstructured":"(2022, November 01). National Institute for Health and Care Excellence (NICE) Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges. Available online: https:\/\/www.nice.org.uk\/guidance\/ng11."},{"key":"ref_3","unstructured":"Fletcher, R., Barnhill, J., and Cooper, S.-A. (2016). Disruptive, impulse-control, and conduct disorders. Diagnostic Manual\u2014Intellectual Disability: A Textbook of Diagnosis of Mental Disorders in Persons with Intellectual Disability, NADD Press. [2nd ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jar.12654","article-title":"Prevalence of co-occurring psychiatric disorders in adults and adolescents with intellectual disability: A systematic review and meta-analysis","volume":"33","author":"Mazza","year":"2020","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1744629518798259","article-title":"Underdiagnosis of psychiatric disorders in people with intellectual disabilities: Differences between psychiatric disorders and challenging behaviour","volume":"24","author":"Arrufat","year":"2020","journal-title":"J. Intell. Disabil."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpsy.2021.10.002","article-title":"The European guideline on the assessment and diagnosis of psychiatric disorders in adults with intellectual disabilities","volume":"36","author":"Deb","year":"2022","journal-title":"Eur. J. Psych."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bertelli, M.O., Deb, S., Munir, K., Hassiotis, A., and Salvador-Carulla, L. (2022). Autism Spectrum Disorder. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder, Springer Nature.","DOI":"10.1007\/978-3-319-95720-3"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bertelli, M.O., Deb, S., Munir, K., Hassiotis, A., and Salvador-Carulla, L. (2022). Attention Deficit Hyperactivity Disorder. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder, Springer Nature.","DOI":"10.1007\/978-3-319-95720-3"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1108\/AMHID-02-2018-0004","article-title":"Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in England part 1-history and background of STOMP","volume":"13","author":"Branford","year":"2019","journal-title":"Adv. Ment. Health Intellect. Disabil."},{"key":"ref_10","unstructured":"Biswas, A., Baldwin, D., Hiremath, A., Jaydeokar, S., Lovell, M., McAlister, H., Shankar, R., Deb, S., Devapriam, J., and Branford, D. (2021). Stopping the Overmedication of People with Intellectual Disability, Autism or Both (Stomp) and Supporting Treatment and Appropriate Medication in Paediatrics (Stamp), Royal College of Psychiatrists."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/j.2051-5545.2009.tb00248.x","article-title":"International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities","volume":"8","author":"Deb","year":"2009","journal-title":"World Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjc.12118","article-title":"Challenging behaviours in adults with an ID: A total population study and exploration of risk indices","volume":"56","author":"Bowring","year":"2017","journal-title":"Br. J. Clin. Psychol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"h4326","DOI":"10.1136\/bmj.h4326","article-title":"Mental illness, challenging behaviour, and psychotropic drug prescribing in people with ID: UK population-based cohort study","volume":"351","author":"Sheehan","year":"2015","journal-title":"Br. Med. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.ridd.2011.07.031","article-title":"Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: A systematic review","volume":"32","author":"Unwin","year":"2011","journal-title":"Res. Dev. Disabil."},{"key":"ref_15","unstructured":"Deb, S., Roy, M., and Limbu, B. (2022). Psychopharmacological treatments for psychopathology in people with intellectual disabilities and\/or autism spectrum disorder. Br. J. Psych. Adv., 1\u201312."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(08)60072-0","article-title":"Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: A randomised controlled trial","volume":"371","author":"Tyrer","year":"2008","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"McQuire, C., Hassiotis, A., Harrison, B., and Pilling, S. (2015). Pharmacological interventions for challenging behaviour in children with intellectual disabilities: A systematic review and meta-analysis. BMC Psychiatry, 15.","DOI":"10.1186\/s12888-015-0688-2"},{"key":"ref_18","first-page":"e017406","article-title":"Movement side effects of antipsychotic drugs in adults with and without ID: UK population-based cohort study","volume":"7","author":"Sheehan","year":"2017","journal-title":"Br. Med. J. Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jir.12777","article-title":"Psychotropic medications use and side effects of individuals with intellectual and developmental disabilities","volume":"64","author":"Charlot","year":"2020","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1080\/14740338.2020.1820985","article-title":"Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: A systematic review","volume":"19","author":"Iasevoli","year":"2020","journal-title":"Expert. Opin. Drug. Saf."},{"key":"ref_21","first-page":"e032861","article-title":"Experiences of psychotropic medication use and decision-making for adults with ID: A multistakeholder qualitative study in the UK","volume":"9","author":"Sheehan","year":"2019","journal-title":"Br. Med. J. Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1468-3148.2008.00454.x","article-title":"Antipsychotic Medication and People with ID: Their Knowledge and Experiences","volume":"22","author":"Crossley","year":"2009","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/bld.12196","article-title":"\u201cTell me what they do my body\u201d: A survey to find out what information people with learning disabilities want with their medications","volume":"45","author":"Fish","year":"2017","journal-title":"Br. J. Learn. Disabil."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1108\/17530180200800005","article-title":"A qualitative study on the knowledge and views that people with learning disabilities and their carers have of psychotropic medication prescribed for behaviour problems","volume":"2","author":"Hall","year":"2008","journal-title":"Adv. Ment. Health Learn. Disabil."},{"key":"ref_25","first-page":"2","article-title":"Multidisciplinary guideline on Problem behavior in adults with intellectual disabilities","volume":"2019","author":"Embregts","year":"2019","journal-title":"Ned. Ver. Van Artsen Voor Verstand. Gehandicap. (NVAVG)"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2215-0366(16)30191-2","article-title":"Reduction or discontinuation of antipsychotics for challenging behaviour in adults with ID: A systematic review","volume":"4","author":"Sheehan","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/jcph.1271","article-title":"An Open-Label Discontinuation Trial of Long-Term, Off-Label Antipsychotic Medication in People With ID: Determinants of Success and Failure","volume":"58","author":"Hoekstra","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/jar.12635","article-title":"A structured programme to withdraw antipsychotics among adults with ID: The Cornwall experience","volume":"32","author":"Shankar","year":"2019","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jar.12528","article-title":"An open-label discontinuation trial of long-term used off-label antipsychotic drugs in people with ID: The influence of staff-related factors","volume":"32","author":"Hoekstra","year":"2019","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Deb, S., Limbu, B., Unwin, G., Woodcock, L., Cooper, V., and Fullerton, M. (2021). Short-term Psycho-Education for Caregivers to Reduce OverMedication of people with intellectual disabilities (SPECTROM): Development and field testing. Intern. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182413161"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jar.12357","article-title":"Knowledge and expectations of direct support professionals towards effects of psychotropic drugs in people with intellectual disabilities","volume":"30","year":"2017","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Deb, S., Limbu, B., Unwin, G.L., and Weaver, T. (2022). Causes of and alternatives to medication for behaviours that challenge in people with intellectual disabilities: Direct care providers\u2019 perspectives. Intern. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19169988"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1192\/bjo.2020.97","article-title":"UK psychiatrists\u2019 experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with ID and\/or autism","volume":"6","author":"Deb","year":"2020","journal-title":"Br. J. Psych. Open"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/jar.12577","article-title":"Support staff\u2019s perceptions of discontinuing antipsychotics in people with ID in residential care: A mixed-method study","volume":"32","author":"Kleijwegt","year":"2019","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"De Kuijper, G., and de Haan, J. Withdrawing antipsychotics for challenging behaviours in adults with intellectual disabilities; prescribers\u2019 experiences and views. Int. J. Environ. Res. Public Health, 2022. submitted.","DOI":"10.3390\/ijerph192417095"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2788.2010.01275.x","article-title":"Use of antipsychotic drugs in individuals with ID (ID) in the Netherlands: Prevalence and reasons for prescription","volume":"54","author":"Hoekstra","year":"2010","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_37","unstructured":"Do\u0161en, A. (2014). Psychische Stoornissen, Probleemgedrag en Verstandelijke Beperking, Koninklijke van Gorcum. (In German)."},{"key":"ref_38","unstructured":"Shosha, G. (2022, November 01). Employment of Colaizzi\u2019s Strategy in Descriptive Phenomenology: A Reflection of a Researcher. Available online: https:\/\/eujournal.org\/index.php\/esj\/article\/view\/588."},{"key":"ref_39","unstructured":"Polit, D., and Beck, C. (2017). Nursing Research. Generating and Assessing Evidence for Nursing Practice, Wolters Kluwer."},{"key":"ref_40","unstructured":"Mortelmans, D. (2020). Handboek Kwalitatieve Onderzoeksmethoden, Acco."},{"key":"ref_41","unstructured":"Hassiotis, A., Kimona, K., Moncrieff, J., and Deb, S. (2022, November 01). A stakeholder Consultation about Future Research of Psychotropic Medication Use and Behaviour Support for Adults with Intellectual Disabilities Who Present with Behaviours that Challenge: Feasibility of Future Research. NOCLOR. Available online: https:\/\/www.ucl.ac.uk\/psychiatry\/sites\/psychiatry\/files\/stakeholder-consultation-document.pdf."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2788.1996.tb00637.x","article-title":"Factors associated with successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities","volume":"40","author":"Branford","year":"1996","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40263-013-0079-5","article-title":"Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: Theoretical background and practical recommendations","volume":"27","author":"Cerovecki","year":"2013","journal-title":"CNS Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000112883","article-title":"Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes","volume":"77","author":"Chouinard","year":"2008","journal-title":"Psychother. Psychosom."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bertelli, M.O., Deb, S., Munir, K., Hassiotis, A., and Salvador-Carulla, L. (2022). Problem behaviours. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder, Springer Nature.","DOI":"10.1007\/978-3-319-95720-3"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/23\/15637\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:26:12Z","timestamp":1760145972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/23\/15637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":45,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijerph192315637"],"URL":"https:\/\/doi.org\/10.3390\/ijerph192315637","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]}}}